Rebuilding the glomerular filtration barrier by regenerating adult podocytes

通过再生成年足细胞重建肾小球滤过屏障

基本信息

  • 批准号:
    9564892
  • 负责人:
  • 金额:
    $ 42.92万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-09-23 至 2020-08-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Adult podocytes are terminally differentiated glomerular epithelial cells without regeneration capacity by self-proliferation. Thus, in states of podocyte depletion, rebuilding the kidney at the level of the glomerular filtration barrier is dependent on podocyte regeneration from stem/progenitor cells. Cells of renin lineage (CoRL) and glomerular parietal epithelial cells (PECs) are two recently identified resident progenitors fo adult podocytes in states of podocyte depletion. In this grant proposal we will fully characterize and evaluate their role and function as adult podocyte progenitors, using our bioengineered 3D flow directed microphysiological system (3D MPS) of the glomerular filtration barrier, initially constituting murine podocytes, matrix and endothelial cells. Specific aim (SA)#1 will characterize and evaluate CoRL and PEC progenitor differentiation and biological functions. SA#2 will optimize reprogramming and plasticity of CoRL and PEC progenitors towards a podocyte fate. SA#3 will broaden and validate the scope of podocyte regeneration by additional stem/progenitor cell types such as induced pluripotent stem cells and mesenchymal stem cells. In addition to the availability of cultured CoRL and PECs progenitors, expected deliverables upon completion of the UH2 includes a unique 3D MPS designed to characterize and evaluate CoRL and PEC progenitor viability, differentiation, phenotype, migration and biological function, using several functional assays. Available progenitor cells for study will initially be of mouse origin, taking advantage of their permanent labeling, as they are derived from cell specific reporter mice. The stemness of other candidate podocyte and/or endothelial cell progenitors can also be tested in this 3D MPS by the consortium. Major deliverables for the UH3 are CoRL and PECs that have been reprogrammed to an enhanced podocyte fate through genetic manipulation, changes to the microenvironment, and exposure to specific therapeutics and growth factors. The 3D MPS will be humanized by replacing mouse cells with human cells, and validation of these in vitro studies will be conducted in vivo in cell specific reporter mice where two cell types of interest are simultaneously labeled. Taken together, this grant will provide novel opportunities for the consortia and others to rebuild the kidney at the level of podocytes by resident and non-resident stem/progenitor cells.
 描述(申请人提供):成体足细胞是终末分化的肾小球上皮细胞,不具有自我增殖的再生能力。因此,在以下状态 足细胞耗竭,在肾小球滤过屏障水平重建肾脏依赖于干/祖细胞的足细胞再生。肾素谱系细胞 (CoRL) 和肾小球壁上皮细胞 (PEC) 是最近鉴定的处于足细胞耗竭状态的成体足细胞的两种常驻祖细胞。在这项拨款提案中,我们将使用我们的生物工程 3D 流动导向微生理系统 (3D MPS) 肾小球滤过屏障(最初由小鼠足细胞、基质和内皮细胞组成)来充分表征和评估它们作为成年足细胞祖细胞的作用和功能。具体目标 (SA)#1 将表征和评估 CoRL 和 PEC 祖细胞分化和生物学功能。 SA#2 将优化 CoRL 和 PEC 祖细胞的重编程和可塑性,以实现足细胞的命运。 SA#3 将通过其他干细胞/祖细胞类型(例如诱导多能干细胞和间充质干细胞)扩大和验证足细胞再生的范围。除了培养的 CoRL 和 PEC 祖细胞的可用性之外,UH2 完成后的预期成果还包括独特的 3D MPS,旨在使用多种功能测定来表征和评估 CoRL 和 PEC 祖细胞的活力、分化、表型、迁移和生物功能。用于研究的可用祖细胞最初将来自小鼠,利用其永久标记,因为它们源自细胞特异性报告小鼠。该联盟还可以在此 3D MPS 中测试其他候选足细胞和/或内皮细胞祖细胞的干性。 UH3 的主要成果是 CoRL 和 PEC,它们已被重新编程,通过基因操作、改变微环境以及接触特定疗法和生长因子来增强足细胞的命运。 3D MPS 将通过用人类细胞替换小鼠细胞来实现人性化,这些体外研究的验证将在细胞特异性报告小鼠体内进行,其中 同时标记两种感兴趣的细胞类型。总而言之,这笔赠款将为该联盟和其他机构提供新的机会,通过以下方式在足细胞水平上重建肾脏: 驻留和非驻留干/祖细胞。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stuart James Shankland其他文献

Stuart James Shankland的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stuart James Shankland', 18)}}的其他基金

The Intersection of Podocyte Disease and Aging
足细胞疾病与衰老的交叉点
  • 批准号:
    10733868
  • 财政年份:
    2023
  • 资助金额:
    $ 42.92万
  • 项目类别:
Targeting Podocyte-Endothelial Cell Crosstalk as a FSGS Therapy
靶向足细胞-内皮细胞串扰作为 FSGS 疗法
  • 批准号:
    10635547
  • 财政年份:
    2023
  • 资助金额:
    $ 42.92万
  • 项目类别:
Autocrine and paracrine podocyte signals decrease glomerular function/health in aged kidneys
自分泌和旁分泌足细胞信号会降低老年肾脏的肾小球功能/健康
  • 批准号:
    10698100
  • 财政年份:
    2022
  • 资助金额:
    $ 42.92万
  • 项目类别:
Kidney Aging Impairs Progenitor and Endocrine Function
肾脏老化损害祖细胞和内分泌功能
  • 批准号:
    10549835
  • 财政年份:
    2020
  • 资助金额:
    $ 42.92万
  • 项目类别:
Kidney Aging Impairs Progenitor and Endocrine Function
肾脏老化损害祖细胞和内分泌功能
  • 批准号:
    10341118
  • 财政年份:
    2020
  • 资助金额:
    $ 42.92万
  • 项目类别:
Cell specific delivery of novel therapies to enhance glomerular regeneration and repair
细胞特异性递送新疗法以增强肾小球再生和修复
  • 批准号:
    10675681
  • 财政年份:
    2020
  • 资助金额:
    $ 42.92万
  • 项目类别:
Cell specific delivery of novel therapies to enhance glomerular regeneration and repair
细胞特异性递送新疗法以增强肾小球再生和修复
  • 批准号:
    10247521
  • 财政年份:
    2020
  • 资助金额:
    $ 42.92万
  • 项目类别:
Cell specific delivery of novel therapies to enhance glomerular regeneration and repair
细胞特异性递送新疗法以增强肾小球再生和修复
  • 批准号:
    10414816
  • 财政年份:
    2020
  • 资助金额:
    $ 42.92万
  • 项目类别:
Reduced Glomerular Progenitors Impair Regeneration in Aged Kidney
肾小球祖细胞减少会损害衰老肾脏的再生
  • 批准号:
    9329346
  • 财政年份:
    2016
  • 资助金额:
    $ 42.92万
  • 项目类别:
Juxta-glomerular cells serve as glomerular epithelial cell progenitors in glomerular disease
肾小球旁细胞在肾小球疾病中充当肾小球上皮细胞祖细胞
  • 批准号:
    10436216
  • 财政年份:
    2014
  • 资助金额:
    $ 42.92万
  • 项目类别:

相似海外基金

Investigating HDAC3 phosphorylation as an epigenetic regulator of memory formation in the adult and aging brain
研究 HDAC3 磷酸化作为成人和衰老大脑记忆形成的表观遗传调节剂
  • 批准号:
    10752404
  • 财政年份:
    2023
  • 资助金额:
    $ 42.92万
  • 项目类别:
The Health of Aging Parents of Adult Children with Serious Conditions
患有严重疾病的成年子女的年迈父母的健康
  • 批准号:
    10660046
  • 财政年份:
    2023
  • 资助金额:
    $ 42.92万
  • 项目类别:
Understanding Longer-Living Older Adult Research: The Summer Program on Aging
了解长寿老年人研究:老龄化夏季项目
  • 批准号:
    476343
  • 财政年份:
    2022
  • 资助金额:
    $ 42.92万
  • 项目类别:
Role of sensory experience in the regulation of plasticity in the developing, adult and aging brain
感官体验在发育、成人和衰老大脑可塑性调节中的作用
  • 批准号:
    RGPIN-2019-04761
  • 财政年份:
    2022
  • 资助金额:
    $ 42.92万
  • 项目类别:
    Discovery Grants Program - Individual
Adult Cognitive and Neurobiological Indicators of Aging: Impact of Adversity and Social Support
成人衰老的认知和神经生物学指标:逆境和社会支持的影响
  • 批准号:
    10365348
  • 财政年份:
    2022
  • 资助金额:
    $ 42.92万
  • 项目类别:
Adult Cognitive and Neurobiological Indicators of Aging: Impact of Adversity and Social Support
成人衰老的认知和神经生物学指标:逆境和社会支持的影响
  • 批准号:
    10700796
  • 财政年份:
    2022
  • 资助金额:
    $ 42.92万
  • 项目类别:
Endogenous barcoding to determine complex dynamics of adult neurogenesis in aging and Alzheimer's disease
内源条形码确定衰老和阿尔茨海默病中成人神经发生的复杂动态
  • 批准号:
    10651861
  • 财政年份:
    2022
  • 资助金额:
    $ 42.92万
  • 项目类别:
Investigating the interface of epigenetics and metabolism underlying memory formation in the adult, aging, and AD brain
研究成人、衰老和 AD 大脑中记忆形成的表观遗传学和代谢界面
  • 批准号:
    10420533
  • 财政年份:
    2022
  • 资助金额:
    $ 42.92万
  • 项目类别:
Endogenous barcoding to determine complex dynamics of adult neurogenesis in aging and Alzheimer's disease
内源条形码确定衰老和阿尔茨海默病中成人神经发生的复杂动态
  • 批准号:
    10846200
  • 财政年份:
    2022
  • 资助金额:
    $ 42.92万
  • 项目类别:
THE DEVELOPMENT OF MECHANISM-BASED ADULT STEM CELL TREATMENTS TO COMBAT AGING PATHOLOGIES
开发基于机制的成人干细胞疗法来对抗衰老病理学
  • 批准号:
    10721544
  • 财政年份:
    2022
  • 资助金额:
    $ 42.92万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了